HIGHLIGHTS
- who: Yi Dong from the Temple University, United States have published the research work: A novel defined m7G regulator signature to investigate the association between molecular characterization and clinical significance in lung adenocarcinoma, in the Journal: (JOURNAL)
- what: In the current analysis, eIF4E3 was downregulated in LUAD compared to the normal samples. To hormone-related tumors, several factors, including inactivating mutations in tumor suppressors (TP53) and activation of oncogenes (EGFR or MYC) in this study, provided clinical insights into m7G in lung cancer. The authors evaluated the role of the m7G regulator in lung adenocarcinoma . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.